DANTE LABS INC.

Dante Labs Inc. specializes in high-throughput genomic sequencing and bioinformatics services for federal research and agricultural programs. The company delivers end-to-end DNA and RNA sequencing workflows, including library preparation, whole-genome analysis, and customized bioinformatic processing using platforms such as NovaSeq X Plus with PE150 read lengths and stringent quality control protocols. Their technical expertise spans plant and animal genomics, with demonstrated proficiency in processing hundreds to thousands of samples per project, ensuring accurate variant calling, assembly, and data interpretation for non-model organisms. Dante Labs differentiates itself through precision in handling complex, low-yield biological samples and delivering tailored analytical pipelines that support agricultural trait discovery and biological characterization. The contractor maintains a strong, recurring relationship with the U.S. Department of Agriculture, consistently supporting genomic research initiatives on cotton, pecan, and other crop species. Their work for USDA involves large-scale sequencing of plant and animal specimens to advance breeding programs and genetic resource preservation. Limited engagements with the Department of Defense and Department of Commerce indicate capacity to support defense-related molecular diagnostics and broader scientific research needs, though USDA remains the primary client. Dante Labs operates primarily within NAICS 541380 (testing laboratories), 541714 (biotechnology R&D), and 541990 (other scientific services), positioning itself as a niche provider of genomic sequencing and bioanalytical services for life sciences and agricultural research. Their market focus is on non-clinical, research-grade genomics, serving federal agencies engaged in biodiversity, crop improvement, and molecular biology studies. As a small business structured as a 2L entity based in New York, NY, Dante Labs operates without federal certifications but maintains a focused presence in the government science and technology procurement market, delivering specialized sequencing capabilities to agencies requiring high-accuracy genomic data generation.